Cabio Biotech (Wuhan) Co., Ltd. (688089.SS) SHH
Currency In CNY
AD
- General
- Statistics
- Historical Data
- Profile
- Financials
AD
Currency In CNY
| Market Cap | 3.88B |
| Enterprise Value | 3.69B |
| P/E Ratio | -6.43 |
| PEG Ratio | 0.19 |
| Price/Sales Ratio | 5.69 |
| Price/Book Ratio | 0.97 |
| Enterprise/Revenue | 5.7 |
| Enterprise/EBITDA | -7.77 |
| Fiscal Year | December 31, 2025 |
| Most Recent Quarter | September 30, 2026 |
| Profit Margin | -0.89 |
| Operating Margin | -0.89 |
| Return On Assets | -0.13 |
| Return On Equity | -0.14 |
| Revenue | 563.14M |
| Revenue/Share | 1.42 |
| Gross Profit | 574.88M |
| EBITDA | 203.16M |
| Net Income | 143.72M |
| Diluted EPS | 0.86 |
| Total Cash | 300.98M |
| Total Cash/Share | 1.81 |
| Total Debt | 139.43M |
| Total Debt/Equity | 0.1 |
| Current Ratio | 4.19 |
| Book Value Per Share | 8.3 |
| 52-Week Change | -67.92 |
| 52-Week High | 26.25 |
| 52-Week Low | 6.91 |
| Moving Average 50 Days | 8.29 |
| Moving Average 200 Days | 12.79 |
| Average Volume | 1.48M |
| Shares Outstanding | 166.36M |
| % Held by Institutions | N/A |
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0 |
| Payout Ratio | -0.01 |
| Last Split Factor | 7:5 |
| Last Split Date | July 18, 2023 |